Ovarian stimulation and assisted reproductive technology outcomes in women transplanted with cryopreserved ovarian tissue: a systematic review.


Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
11 2019
Historique:
received: 24 04 2019
revised: 21 06 2019
accepted: 02 07 2019
pubmed: 9 10 2019
medline: 20 5 2020
entrez: 10 10 2019
Statut: ppublish

Résumé

To systematically review reproductive outcomes of assisted reproductive technology (ART) treatment in women transplanted with frozen-thawed ovarian tissue. Systematic review in accordance with guidelines from Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Not applicable. Women undergoing ovarian tissue transplantation (OTT) and subsequent ART. Literature search in PubMed and Scopus databases. Time from OTT to initiation of ART, stimulation protocol, and conventional ART outcome measures. Twenty studies (including 15 case reports), specifying ART treatments and outcomes of 40 women undergoing OTT were identified. Multiple stimulation protocols were applied, with the modified natural cycle as the most frequently used. In total, 195 ART cycles were performed (4.0 cycles per patient) resulting in 1.5 follicles and 1.0 mature oocyte retrieved per cycle. Empty follicle rates ranged from 23% to 35% in the three largest cohort studies. Twenty-five women (62.5%) had one or more pregnancies, of which 28.6% were lost, resulting in a total of 20 live births (22 children). Overall the pregnancy rates varied from 3.9% to 19.3% and live-birth rates from 3.9% to 14.0% per cycle in the three cohort studies. Fertility treatment was initiated shortly after OTT in some centers, while others awaited natural conception before embarking on ART treatment. The reported pregnancy and live-birth rates for women undergoing OTT and ART were considerably lower than those of the general in vitro fertilization (IVF) population, corresponding to patients with poor ovarian reserve. In general, ART outcomes are underreported, and there is a lack of consensus regarding the timing of ART in relation to OTT and the type of ovarian stimulation protocol.

Identifiants

pubmed: 31594631
pii: S0015-0282(19)30581-3
doi: 10.1016/j.fertnstert.2019.07.008
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

908-921

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Signe Taasti Andersen (ST)

Laboratory of Reproductive Biology, Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Copenhagen, Denmark.

Susanne Elisabeth Pors (SE)

Laboratory of Reproductive Biology, Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Copenhagen, Denmark.

Liv la Cour Poulsen (LC)

The Fertility Clinic, Department of Gynecology and Obstetrics, Zealand University Hospital, Køge, Denmark.

Lotte Berdiin Colmorn (LB)

The Fertility Clinic, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.

Kirsten Tryde Macklon (KT)

The Fertility Clinic, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.

Erik Ernst (E)

The Fertility Clinic, Horsens Regional Hospital, Horsens, Denmark.

Peter Humaidan (P)

The Fertility Clinic, Skive Regional Hospital and Faculty of Health, Aarhus University, Skive, Denmark.

Claus Yding Andersen (CY)

Laboratory of Reproductive Biology, Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Copenhagen, Denmark.

Stine Gry Kristensen (SG)

Laboratory of Reproductive Biology, Juliane Marie Centre for Women, Children and Reproduction, University Hospital of Copenhagen, Copenhagen, Denmark. Electronic address: stine.gry.kristensen@regionh.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH